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ABSTRACT
It has long been accepted that the complement of follicles within the ovary is formed before birth in
humans, or shortly after birth in rodents, and that no follicles are formed thereafter. This follows entry
of all oogonia into meiosis in fetal life, with no remaining germ stem cells in the ovary, in contrast to
the presence of spermatogonia in the testis. This has been brought back into debate in recent years,
following the demonstration of isolation of cells expressing both germline and stem markers from the
postnatal ovary in several species, including humans. We describe these cells as putative ovarian stem
cells. Isolation of these cells is challenging, adding to the debate as to their existence, and the validity
of DDX4 as the main marker used for their isolation has also to be questioned. While different groups
have used varying techniques and indeed terminology to describe these cells, the body of evidence
regarding their initial characterization after isolation is growing. There remain very limited data regard-
ing their developmental potential, but the demonstration of the production of functional oocytes from
induced pluripotent stem cells and the advances in ovarian follicle culture techniques provide a basis
for such studies.
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The mammalian ovary is a highly dynamic organ that under-
goes many structural and functional changes as it fulfills its
two major roles of producing female gametes and the syn-
thesis of sex steroids. In the human ovary, germ cells
(oocytes) are formed during fetal life and they are enclosed
within somatic cells (granulosa cells) to form primordial fol-
licles. The primordial follicles consist of an oocyte, arrested at
the diplotene (dictyate) stage of prophase I of meiosis, sur-
rounded by a few flattened somatic cells (granulosa cells).
For many years it has been assumed that there is a limited
period during which oocytes can be formed and that the
adult ovary has no capacity for germ cell renewal, and there-
fore primordial follicles represent a pool of oocytes that
must last the woman throughout her reproductive lifespan
(Figure 1).
The management of ovarian insufficiency and failure,
including infertility caused by aging or damage, is largely
based on the belief that the entire germ cell (oocyte) pool is
present by the time of birth and that ovaries lose their cap-
acity for oocyte renewal (oogenesis) under physiological and
perturbed conditions. Whether the adult mammalian ovary
has any capacity to undergo postnatal germ cell renewal has
been the subject of debate for almost a century2. The con-
sensus since the 1950s has been that the population of
primordial follicles is fixed before or around the time of birth,
depending on the species3. Although exceptions have been
recognized; the existence of a continuous germline lineage
has been identified in the ovaries of prosimian primates for
many years4. The existence of similar cells in the ovaries of
adult human ovaries had not been actively studied
until recently.
The publication of a study proposing germ cell renewal in
adult mice5 reopened the debate on germ cell renewal and
has led to several studies in a number of mammalian species
that have identified cells with potential for germ cell devel-
opment. The isolation and identification of oocyte-producing
germline cells, in ovaries of adult mammals in general, and
humans in particular, remained elusive until 2009 when puta-
tive germline stem cells were isolated from adult mouse ova-
ries6 and then subsequently from human ovaries7. However,
opinion remains divided with regard to the existence, signifi-
cance, and derivation of these putative germline stem cells.
Critics have argued that experimental techniques, data ana-
lysis, and interpretation are flawed in studies that have iden-
tified putative female germline stem cells, and that in vitro
expansion could explain the presence of germline markers in
mitotically active cells derived from adult mammalian ova-
ries. Many of the early criticisms have been addressed by fur-
ther studies but it is clear that the isolation of these cells is
difficult, with several groups unable to identify them. This
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review will focus on the evidence available to support the
existence and potential of putative germline stem cells in
the adult mammalian ovary, focusing particularly on humans.
Isolation and identification of cells
Whilst this remains a controversial area, there is now a large
body of experimental evidence that demonstrates the exist-
ence of cell populations with molecular characteristics con-
sistent with germline cells within the adult ovary of several
mammalian species, including humans. The physiological sig-
nificance of these cell populations still needs to be clarified
but, given that adult stem cells have now been identified in
most organ systems, it would seem likely that the ovary con-
tains stem cells for all component cell types8.
Central to the identification of these cells is their ability to
undergo mitotic division, to express proteins associated with
the germline, such as DDX4, KIT, DPPA3, IFITM3, and PRDM1,
and with pluripotency, including POU5F1, LIN28, and
NANOG. Several studies have now demonstrated the isola-
tion of mitotic cells expressing germline markers from ova-
ries of adult rodents6,7,9–11, cows12, sheep13, primates14, and
humans7,12,13,15–18. These cells have been called female
germline stem cells, oogonial stem cells (OSCs), egg precur-
sor cells, or indeed very small embryonic-like stem cells. In
this review the cells will be referred to as putative OSCs in
recognition that these cells have yet to be fully characterized
and their true stem cell potential determined.
The populations of cells that have been isolated by differ-
ent groups may not represent a homogeneous group. The
emerging evidence suggests that there are different popula-
tions of putative stem cells within the adult ovary, some
with germline characteristics and others with somatic cell
characteristics. Isolation of putative OSCs has been based on
the expression of the RNA helicase DEAD box polypeptide 4
(DDX4), which within the ovary is found only in the germline,
using fluorescence-activated cell sorting (FACS) or magnetic-
activated cell sorting. Isolated cells are then analyzed to
determine the presence of other germline and stem cell
markers. The reliance upon DDX4 as a marker to isolate
these cells has attracted criticism19–21. Much of this criticism
has centered around the assumption that DDX4 is only an
intracellular protein and does not have a surface epitope22.
DDX4 is expressed in the cytoplasm of oocytes and not on
the surface but it has been found to be localized to the
nucleus, cytoplasm, or membrane bound in a range of tis-
sues and cells, with potentially dynamic localization depend-
ing upon the cellular context23. This is contrary to the
assertion that DDX4 cannot be expressed on the cell surface.
Recently published data from our laboratories showed that
populations of cells expressing DDX4 can be isolated from
adult human ovary using commercially available antibodies
to DDX4, and clearly demonstrate that DDX4 can be
detected on the surface of the freshly isolated cells
(Figure 2)15.
That several groups have been unable to isolate these
cells or detect DDX4 expression is probably indicative of
technical issues associated with cell dissociation and sorting,
particularly from the human ovary which is much tougher
than the rodent ovary with which most investigators in the
field are more familiar. It is clear that the cells are sensitive
and harsh dissociation methods may result in excessive cell
death. The technique reported by Clarkson et al.15 describes
a gentler modified dissociation method than that originally
described by the Tilly group,7 which results in high cell sur-
vival prior to FACs. This refined methodology used a widely
recognized marker of viable stem cells, aldehyde dehydro-
genase 1 (ALDH1)24, in combination with antibodies against
Figure 1. Schematic of the key stages of oocyte maturation. Upper panel: proliferative primordial germ cells (PGCs) form nests and then enter meiosis during fetal
life. Nest breakdown results in the formation of primordial follicles. Lower panel: after growth activation, follicles progress through the stated phases, with the
oocyte ultimately reentering meiosis and being released from the follicle. Sizes given are of the oocyte, not the follicle, showing how it also grows dramatically dur-
ing this process. Reproduced from Anderson and Telfer1 with permission.
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the external C-terminus of DDX4 for FACS of dissociated
human ovarian cells. By combining these two markers, cells
positive for DDX4 with varying degrees of stem cell capacity
could be identified. The addition of this ALDH1 marker facili-
tates the isolation and identification of potential subpopula-
tions of putative OSCs (Figure 3)15.
Development of putative OSCs into oocytes
Putative OSCs are characterized by expression of primitive
germ cell-specific and stem cell markers7,15,25. Isolated puta-
tive OSCs express germline markers (DDX4, KIT, DPPA3,
IFITM3, and PRDM1) and pluripotency markers (POU5F1,
LIN28, and NANOG), but not oocyte/follicle markers
(CYP19A1, HDAC6, or ZP3). Transplantation of in vitro
expanded green fluorescent protein-labeled mouse putative
OSCs back into ovaries leads to the generation of fertiliza-
tion-competent eggs that produce viable embryos and off-
spring6. Cells with similar characteristics have been isolated
from adult human ovaries7,15,18. Cultured putative OSCs
maintain a germline profile while actively dividing and have
been shown to form oocyte-like structures in vitro after pro-
longed culture7,18,26 or short-term culture15,18. Fluorescently
labeled human putative OSCs have generated green fluores-
cent protein-positive oocyte-like cells enclosed in host som-
atic cells, as assessed by morphology and expression of
oocyte-specific markers after injection into adult human
ovarian cortical tissue and xenotransplantation into an
immune-deficient mouse for 7 days26. The formation of
oocyte/follicle-like structures under these conditions has
been explained as an in vitro transformation and not indica-
tive of the true potential of the isolated cells. However,
recent studies have demonstrated that freshly sorted human
cells, analyzed without in vitro culture, express both germline
and stem cell markers15,18. Furthermore, oocyte/follicle-like
structures can be formed from freshly isolated human puta-
tive OSCs when combined with human fetal ovarian somatic
cells to form aggregates during a culture period of 7 days15.
Therefore, the developmental potential of the isolated cells
cannot be dismissed as being an in vitro artifact.
Recent work has identified subpopulations of human
putative OSCs based on their gene expression profile15. This
may be significant in terms of developmental potential as
they show some parallels with normal human germ cell
developmental stages27. Sorting of cells using DDX4 and
ALDH1 identified two distinct populations of cells of similar
size (P1, P2) characterized by the presence or absence of the
RNA binding protein Deleted in azoospermia-like (DAZL).
DAZL is a major regulator of germ cell differentiation and
Figure 2. (A) Immunocytochemistry of DEAD box polypeptide 4 (DDX4) expression in freshly sorted human putative oogonial stem cells (‘uncultured cells’), with
40,6-diamidino-2-phenylindole (DAPI) staining of DNA in DDX4-negative cells (centre panel, and merged image (right panel). (B) DDX4 and DAPI staining of putative
oogonial stem cells after culture in aggregates of human fetal ovarian somatic cells. Methods as described in Clarkson et al.15.
Figure 3. Flow cytometry plot illustrating selection of subpopulations of sorted
ovarian cells based on cell size, presence of DEAD box polypeptide 4 (DDX4),
and intensity of aldehyde dehydrogenase 1 (ALDH1). Methods as described in
Clarkson et al.15. Populations 1 and 2 (P1, P2) are of similar size but differ in
the degree of ALDH1 intensity and expression pattern. Populations 2 and 3 (P2,
P3) have similar intensities of ALDH1 and DDX4 but cells in population 3 are
significantly larger. FSC, forward scatter.
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essential for progression into meiosis28,29. DAZL is present in
the P2 population but not in P1. Human studies have shown
that DAZL expression is significantly upregulated in germ
cells around the time of meiotic entry27, thus the cells col-
lected in P2 may represent a more differentiated population
that have greater potential to form functional gametes if
given the right support15. The identification of subpopula-
tions of putative OSCs could account for the lack of uniform-
ity between results presented by investigators seeking to
isolate a standardized single population of cells by FACS22,30.
Identifying and isolating cells with germline potential
from the human ovary represents a major advance and could
have many practical applications for human fertility, most
clearly in assisted reproduction and fertility preservation/res-
toration. In order to make progress, it is essential to charac-
terize fully the isolated cell populations that various groups
have identified and to reach a consensus as to whether the
cells are indeed stem cells or unipotent progenitor cells. The
‘oocyte-like’ cells derived from putative OSCs in vitro require
somatic cell support and development of paracrine and junc-
tional communication to form follicles if functional oocytes
are to be produced. Developing these ‘oocyte-like’ cells in
vitro will require developmentally appropriate culture sys-
tems including systems that support oocyte development
from the earliest stages. If functional oocytes could be
derived from putative OSCs and developed in vitro, this
would indeed widen options for fertility preservation and
restoration.
Supporting oocyte formation from putative OSCS
and growth in vitro
Complete oogenesis has been achieved in vitro starting from
induced pluripotent stem cells derived from mice31–34. These
studies clearly demonstrate the crucial role of somatic cells
in supporting germ cell development from these earliest
stages. Recapitulating this process in vitro using human-
derived induced pluripotent stem cells has been much more
problematic and so far can only reach the stage of oogonia
(Science paper Saitou group).32 In contrast, isolated human
putative OSCs form oocyte/follicle structures in vitro and
after transplantation in vivo7,15. The ability to obtain forma-
tion of follicles/oocytes from these cells enables characteriza-
tion studies to be carried out. Expression patterns of factors
required for early oocyte development as well as factors
associated with entry into meiosis need to be determined, as
well as detailed sequencing of populations of cells isolated
from the adult ovary. Alongside characterization studies, the
challenge will be to determine whether functional oocytes
can be obtained from putative OSCs and this will require the
development of defined culture systems. Systems that sup-
port the growth and development of immature human
oocytes in vitro have been developed35,36 and will be invalu-
able for this work, although requiring optimization.
The concept of growing immature oocytes in vitro has
been the subject of a great deal of research for almost
30 years. Complete growth in vitro from the most immature
oocytes (primordial stages) with subsequent in vitro
fertilization and production of live young has been achieved
in mice37,38. Early work on this two-step culture system
resulted in only one live offspring being obtained and this
mouse had many abnormalities as an adult37. Following
improvements in the technique and after modifications to
the culture medium, several mouse embryos and offspring
were obtained from in vitro grown oocytes combined with in
vitro maturation and in vitro fertilization 38. This work has
provided a proof of concept that complete oocyte develop-
ment can be achieved in vitro and has driven the develop-
ment of culture systems that could be applied to other
species, particularly humans. The multistep culture systems
that support the growth and development of immature
human oocytes in vitro from primordial follicles right through
to fully grown oocytes capable of meiotic maturation to
metaphase II36 provide a robust and extensive ex vivo test of
the potential of any oocyte-like cells that are formed from
putative OSCs.
Summary
There now exists a body of experimental evidence that sup-
ports the existence of cells with molecular characteristics
consistent with germline progenitor/stem cells within the
ovaries of a range of species, including in adult women.
Different methods of isolation and characterization have
been used and different terminologies exist to describe these
cells, leading to some confusion. Ongoing research is con-
tinuing in several laboratories to further define and charac-
terize cell types within the adult human ovary. The potential
physiological relevance of these cells to adult ovarian func-
tion and fertility remains unknown, but their existence raises
questions about why they do not appear to contribute to
postnatal follicle formation, whether that is in fact correct,
and if, how, and when their potential could be harnessed.
Whilst there remains controversy over the biological signifi-
cance of these cells, it must be acknowledged that their
identification and isolation represent a significant advance
with the potential to change infertility treatments, and pos-
sibly even the non-reproductive consequences of the loss of
ovarian function, in the future.
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